Clinical Trials Sponsored by Institute of Cancer Research (ICR), United Kingdom

Total 510 results

Institute of Cancer Research, United Kingdom

Recruiting

PreOperative Endocrine Therapy for Individualised Care With Abemaciclib (POETIC-A)

Breast Cancer Female

United Kingdom
Institute of Cancer Research, United Kingdom

Recruiting

PUMA (Paediatric Osseous Marrow Assessment) (PUMA)

Leukaemia

United Kingdom
Institute of Cancer Research, United Kingdom

Active, not recruiting

The BARCODE 1 Pilot Study (BARCODE1Pilot)

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Completed

MR-HIFU for Recurrent Gynaecological Cancer (HIFU-Gynae)

Cervical Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Uterine Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Unknown

Exploring the Link Between Cancer Genetics and PPSP

Breast Cancer | Cancer-related Pain | Chronic Post Cancer Surgery Pain
Institute of Cancer Research, United Kingdom

Unknown

The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver (VISUAL)

Liver Neoplasms
Institute of Cancer Research, United Kingdom

Terminated

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer (EVOLUTION)

Metastatic Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Recruiting

Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment (PERMIT)

Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Active, not recruiting

Stereotactic Body Radiotherapy for the Treatment of OPD (HALT)

NSCLC

United Kingdom, France, Switzerland, Italy, Spain
Institute of Cancer Research, United Kingdom

Completed

Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours

Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Completed

Radiation Therapy in Treating Women With Localized Breast Cancer (FAST)

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Completed

Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer

Bladder Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Active, not recruiting

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery (TACT2)

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Recruiting

Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer (HERMES)

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Recruiting

PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy

Adenocarcinoma

United Kingdom
Institute of Cancer Research, United Kingdom

Recruiting

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations (GENPROS)

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Active, not recruiting

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. (BARCODE1)

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Active, not recruiting

Trial of Perioperative Endocrine Therapy - Individualising Care (POETIC)

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Unknown

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Completed

MR Characterisation/Localisation of Breast Cancer

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
National Institute for Health Research, United Kingdom

Unknown

Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer (CALIBER)

Bladder Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK; National Institute for Health Research, United Kingdom

Completed

Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome (SIGNIFY)

Li-Fraumeni Syndrome

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK; National Institute for Health Research, United Kingdom

Recruiting

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation. (GENPET)

Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation

United Kingdom
Institute of Cancer Research, United Kingdom
GlaxoSmithKline

Completed

Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer (MAPLE)

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
AstraZeneca

Recruiting

PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer (PHOENIX)

Breast Neoplasm

United Kingdom
AstraZeneca
Institute of Cancer Research, United Kingdom

Completed

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Breast Cancer

Italy
Institute of Cancer Research, United Kingdom
Cancer Research UK

Unknown

A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) (POUT)

Transitional Cell Carcinoma of Ureter

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Completed

Lactate Imaging as a Tumour Biomarker

Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Completed

Assessing Treatment Response in Breast Cancer With Functional Imaging

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Terminated

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Endometrial Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Active, not recruiting

Study of Weekly Radiotherapy for Bladder Cancer (HYBRID)

Bladder Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Completed

Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer

Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Unknown

Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery (IMPORT)

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK

Unknown

A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer (PIVOTAL)

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Kortuc, Inc.

Recruiting

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

Breast Cancer

United Kingdom, India
Institute of Cancer Research, United Kingdom
Kortuc, Inc.

Completed

KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response

Breast Cancer

United Kingdom
Chroma Therapeutics
Institute of Cancer Research, United Kingdom

Completed

Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours

Advanced Solid Tumors
Institute of Cancer Research, United Kingdom
Verastem, Inc.

Active, not recruiting

Phase I Trial of Defactinib and VS-6766. (FRAME)

Pancreatic Cancer | NSCLC | Low Grade Serous Ovarian Cancer | Endometrioid Carcinoma

United Kingdom
Institute of Cancer Research, United Kingdom
AstraZeneca; Cancer Research UK

Recruiting

ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss or no Loss (ATARI)

Gynaecological Cancers

United Kingdom
Institute of Cancer Research, United Kingdom
Prostate Cancer UK

Recruiting

A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT (PACE-NODES)

Prostate Cancer

United Kingdom
Institute of Cancer Research, United Kingdom
Prostate Cancer UK

Recruiting

Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO (MAESTRO)

Castration-resistant Prostate Cancer | Metastatic Prostate Cancer

United Kingdom
Ludwig Institute for Cancer Research
Institute of Cancer Research, United Kingdom

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

Melanoma

United Kingdom, Australia, New Zealand
Institute of Cancer Research, United Kingdom

Unknown

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

Bladder Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Unknown

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

Head and Neck Cancer | Ototoxicity | Radiation Toxicity

United Kingdom
Institute of Cancer Research, United Kingdom

Completed

Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

Melanoma (Skin)

United Kingdom
Institute of Cancer Research, United Kingdom

Completed

Positron Emission Tomography in Detecting Testicle Cancer

Testicular Germ Cell Tumor

United Kingdom
Institute of Cancer Research, United Kingdom
National Cancer Institute (NCI)

Unknown

17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Institute of Cancer Research, United Kingdom

Unknown

Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United Kingdom
Institute of Cancer Research, United Kingdom

Unknown

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

Malignant Mesothelioma

United Kingdom
Institute of Cancer Research, United Kingdom

Unknown

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Cancer

United Kingdom, Belgium

Clinical Trials Sponsored by Institute of Cancer Research (ICR), United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations